The Enterprise Value as of June 2026 (TTM) for Innovent Biologics, Inc. (IVBXF) is 97.37B

According to Innovent Biologics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 97.37B. This represents a change of 21.08% compared to the average of 80.42B of the last 4 quarters.

Innovent Biologics, Inc. (IVBXF) Historical Enterprise Value (quarterly & annually)

How has IVBXF Enterprise Value performed in the past?

The mean historical Enterprise Value of Innovent Biologics, Inc. over the last ten years is 46.89B. The current 97.37B Enterprise Value has changed 20.67% with respect to the historical average. Over the past ten years (40 quarters), IVBXF's Enterprise Value was at its highest in in the June 2025 quarter at 115.61B. The Enterprise Value was at its lowest in in the June 2016 quarter at 0.

Innovent Biologics, Inc. (IVBXF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Innovent Biologics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Innovent Biologics, Inc. (IVBXF) Average Enterprise Value

How has IVBXF Enterprise Value performed in the past?

The current Enterprise Value of Innovent Biologics, Inc. (IVBXF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Innovent Biologics, Inc. (IVBXF) Enterprise Value vs. Peers

How is IVBXF’s Enterprise Value compared to its peers?

Innovent Biologics, Inc.’s Enterprise Value is greater than Genmab A/S (19.32B), less than WuXi Biologics (Cayman) Inc. (100.50B), less than WuXi Biologics (Cayman) Inc. (100.50B), greater than Sino Biopharmaceutical Limited (79.40B), greater than Sino Biopharmaceutical Limited (79.40B), greater than Sartorius AG (19.48B), less than Astellas Pharma Inc. (4.10T), greater than bioMérieux S.A. (7.89B), greater than Grifols, S.A. (15.09B), less than Astellas Pharma Inc. (4.10T),

Build a custom stock screener for Innovent Biologics, Inc. (IVBXF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Innovent Biologics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Innovent Biologics, Inc. (IVBXF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Innovent Biologics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.